Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2025)

Inspire Medical Systems' Cash from Investing Activities history spans 9 years, with the latest figure at -$11.9 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 416.88% year-over-year to -$11.9 million; the TTM value through Dec 2025 reached $21.4 million, up 118.96%, while the annual FY2025 figure was $21.4 million, 118.96% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$11.9 million at Inspire Medical Systems, down from -$11.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $46.6 million in Q2 2025 and bottomed at -$151.7 million in Q4 2023.
  • The 5-year median for Cash from Investing Activities is -$2.3 million (2022), against an average of -$18.8 million.
  • The largest annual shift saw Cash from Investing Activities plummeted 5043.15% in 2023 before it skyrocketed 728.51% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$533000.0 in 2021, then crashed by 453.47% to -$2.9 million in 2022, then tumbled by 5043.15% to -$151.7 million in 2023, then soared by 102.48% to $3.8 million in 2024, then tumbled by 416.88% to -$11.9 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Cash from Investing Activities are -$11.9 million (Q4 2025), -$11.6 million (Q3 2025), and $46.6 million (Q2 2025).